Update: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

If your email program has trouble displaying this email, view as a webpage.

FDA - Center for Devices and Radiological Health

Update: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests 

Today, the U.S. Food and Drug Administration (FDA) posted an update to the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. 

The update added new information about a potential impact on the performance of the Mesa Biotech Inc. Accula SARS-CoV-2 Test due to a genetic mutation at positions 28877-28878 (AG to TC) in patient samples. 

Read More


If you have questions about this update, email COVID19DX@fda.hhs.gov